6-methoxy-2-naphthylacetic acid has been researched along with dinoprostone in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blower, PR; Gentry, C; Kelvin, AS; Melarange, R; Neil, C; O'Connell, C; Toseland, CD | 1 |
Barradas, MA; Dandona, P; Jeremy, JY; Kirk, RM; Mikhailidis, DP | 2 |
Fujioka, H; Kokubu, T; Matsui, N; Mizuno, K; Tsunoda, M | 1 |
Hirst, JJ; Poore, KR; Young, IR | 1 |
Itoh, H; Mizuno, K; Onga, T; Saura, R | 1 |
Brezis, M; Cohen, S; Goldfarb, M; Heyman, SN; Karmeli, F; Reichman, J; Rosen, S; Shina, A | 1 |
Doita, M; Kurosaka, M; Miyamoto, H; Mizuno, K; Saura, R | 1 |
8 other study(ies) available for 6-methoxy-2-naphthylacetic acid and dinoprostone
Article | Year |
---|---|
Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Carrageenan; Dinoprostone; Gastric Mucosa; Indomethacin; Inflammation; Injections, Intravenous; Nabumetone; Naphthaleneacetic Acids; Rats; Rats, Wistar | 1992 |
Effects of the prodrug nabumetone, and its active metabolite, 6-MNA, on human and rat gastric mucosal prostanoids and platelet function.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Butanones; Dinoprostone; Epoprostenol; Gastric Mucosa; Humans; Indomethacin; Male; Nabumetone; Naphthaleneacetic Acids; Naproxen; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Rats; Rats, Inbred Strains | 1990 |
The effect of nabumetone and its principal active metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function.
Topics: 6-Ketoprostaglandin F1 alpha; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Butanones; Culture Techniques; Dinoprostone; Epoprostenol; Gastric Mucosa; Humans; Indomethacin; Nabumetone; Naphthaleneacetic Acids; Naproxen; Platelet Aggregation; Thromboxane A2; Thromboxane B2 | 1990 |
Low intensity pulsed ultrasound exposure increases prostaglandin E2 production via the induction of cyclooxygenase-2 mRNA in mouse osteoblasts.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Isoenzymes; Membrane Proteins; Mice; Naphthaleneacetic Acids; Osteoblasts; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Tumor Cells, Cultured; Ultrasonics; Up-Regulation; Wound Healing | 1999 |
Efficacy of the selective prostaglandin synthase type 2 inhibitor nimesulide in blocking basal prostaglandin production and delaying glucocorticoid-induced premature labor in sheep.
Topics: Animals; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprost; Dinoprostone; Electromyography; Female; Fetal Blood; Glucocorticoids; Naphthaleneacetic Acids; Obstetric Labor, Premature; Pregnancy; Prostaglandins; Sheep; Sulfonamides; Uterus | 1999 |
Effect of prostaglandin E2 on nitric oxide synthesis in articular chondrocytes.
Topics: Adenylyl Cyclases; Animals; Cartilage, Articular; Cattle; Cells, Cultured; Chondrocytes; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Activation; Interleukin-1; Naphthaleneacetic Acids; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; RNA, Messenger | 2000 |
Renal effects of nabumetone, a COX-2 antagonist: impairment of function in isolated perfused rat kidneys contrasts with preserved renal function in vivo.
Topics: Acute Kidney Injury; Animals; Cyclooxygenase Inhibitors; Dinoprostone; Hemodynamics; In Vitro Techniques; Kidney; Male; Naphthaleneacetic Acids; Perfusion; Rats; Rats, Sprague-Dawley; Renal Circulation; Time Factors | 2001 |
The role of cyclooxygenase-2 in lumbar disc herniation.
Topics: Adolescent; Adult; Cells, Cultured; Culture Media, Conditioned; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gene Expression Regulation; Humans; Immunohistochemistry; Intervertebral Disc Displacement; Isoenzymes; Lumbar Vertebrae; Lumbosacral Region; Male; Membrane Proteins; Middle Aged; Naphthaleneacetic Acids; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spinal Fractures | 2002 |